David Sinclair, a Harvard genetics professor and aging researcher, discusses how AI is revolutionizing longevity science with host Tom Bilyeu. Sinclair leads a lab that has successfully demonstrated age reversal in mice and monkeys using both genetic and chemical approaches.

The conversation explores Sinclair's information theory of aging, which proposes that aging results from cells losing the ability to read their genetic instructions correctly due to DNA methylation pattern disruption. His lab has developed AI systems that can identify aging biomarkers and screen billions of potential anti-aging compounds virtually.

Sinclair reveals breakthrough results across multiple diseases including Alzheimer's, ALS, multiple sclerosis, and blindness, all approached through the lens of cellular age reversal rather than traditional disease-specific treatments. The discussion also touches on the ethical implications of growing conscious mini-brains in laboratories.

AI Accelerates Anti-Aging Drug Discovery by 160 Years

Sinclair's lab has screened 8 billion virtual chemicals for aging reversal using AI, a process that would have taken '160 years and many billions of dollars' using traditional methods

The breakthrough relies on protein structure data from DeepMind's AlphaFold, allowing virtual docking of billions of molecules to find ones that modulate aging-related proteins

The lab trained its own machine learning model from scratch using millions of human cells, teaching it to distinguish young cells from old cells through visual pattern recognition

An AI agentic system developed with Stanford collaborators made novel discoveries about biological age prediction, autonomously writing a complete research paper

The Information Theory of Aging and Cellular Reset

Aging occurs when sirtuins (regulatory proteins) get distracted from maintaining DNA methylation patterns because they prioritize repairing broken chromosomes

Sinclair's team proved this by using a slime mold enzyme to create strategic DNA breaks in young mice, causing them to age 50% faster with identical symptoms to natural aging

Cells contain a 'backup copy' of youthful information that can be accessed using three genes (OCT4, SOX2, KLF4) or three chemicals to reverse cellular age

The reversal process stops at about 75% to prevent cells from becoming pluripotent, which would cause cancer or loss of cellular identity

Human embryos are initially the same age as their parents (around 30 years old) but reset to age zero between days 7-9 post-conception

Breakthrough Results Across Multiple Diseases

The lab has successfully reversed aging in mouse brains, with old mice regaining learning ability and recovering childhood memories

Multiple diseases have been addressed through age reversal including multiple sclerosis, ALS, kidney disease, liver disease, and skin aging

Monkey eye trials showed successful reversal of aging-related blindness, with restored electrical signals in the optic nerve

Cancer cells actually slow down or die when reprogrammed, making de-aging safer than initially feared - 'I'm not worried actually about cancer anymore' - Sinclair

The approach targets aging as the root cause rather than individual diseases: 'Most of Alzheimer's is aging. You don't get Alzheimer's typically when you're 12'

Growing Human Mini-Brains and Ethical Implications

Sinclair's lab grows miniature human brains with recognizable brain structures that develop eyes and produce measurable brain waves

These mini-brains can be artificially aged to develop Alzheimer's-like conditions, then reversed using the same protocols tested in mice

The consciousness question remains unanswered: 'I don't know, but they have brain waves. We don't know what they're thinking' - Sinclair

Human clinical trials for eye aging reversal are planned for this year, focusing on treating blindness through localized gene therapy